|
traditional
| Date |
Article Rating |
Type |
Title |
|
Jul 23, 2004 |
 |
Article,DrugNews |
Two Alzheimer's Drugs Show Potential - U.S. Studies
Two experimental Alzheimer's drugs have the potential to prevent or halt the progress of the brain-wasting disease, doctors said on Wednesday, July 21, 2004. |
|
Jun 30, 2004 |
|
Article |
Drugs Offer Hope for Alzheimer's?
In a significant advancement for the next generation of Alzheimer's treatments, Neurochem Inc. says it will begin recruiting patients for a large efficacy trial of its drug Alzhemed in the next few weeks. |
|
Dec 22, 2003 |
|
Article,DrugNews |
Clinical Trial of Alzheimer's Disease Drug Shows Clear Reductions in AD Development
A new clinical trial has shown that a treatment for Alzheimer's disease slowed the progression of cognitive decline in a group of patients with moderate to severe symptoms. The findings of the trials into the effectiveness of the drug Clioquinol on the treatment of AD, were carried out by University College of London's Department of Psychiatry and Behavioural Sciences and Prana Biotechnology Limited. |
|
Dec 08, 2004 |
|
Article |
Two New Alzheimer's Treatments Patented
The Blanchette Rockefeller Neurosciences Institute has patented two new potential treatments for Alzheimer's disease. One treatment uses bryostatin, a cancer treatment drug. |
|
Nov 08, 2004 |
|
Article,DrugNews |
New Compounds Effective Against Alzheimer's Disease Onset and Progression
Drug discovery researchers at Northwestern University have developed a new class of compounds that have the potential to reduce the inflammation of brain cells and the neuron loss associated with Alzheimer's disease. |
|
Apr 29, 2004 |
|
Article,DrugNews |
Ceregene Confirms Plans to Further Develop Alzheimer's Disease Gene Therapy
Ceregene, Inc., today announced that based on preliminary findings in a study conducted at the University of California, San Diego (UCSD), it will advance its gene therapy for Alzheimer's disease into further clinical development. |
|
Jan 19, 2004 |
|
Article |
Metal Chelation Therapy May Ease Alzheimer's Disease
A new approach in treating Alzheimer's disease may help improve mental functioning in those with the most severe forms of the disease. A preliminary study indicates that metal chelation therapy, which targets the proteins involved in creating brain plaques that affect people with Alzheimer's disease, may help slow the progression of the disease. |
|
Sep 24, 2003 |
|
DrugNews |
Forest Memantine Cognition Data Will Be Central Question At Cmte. Meeting
Cognition data for Forest's memantine, or lack thereof, in patients with moderate-to-severe Alzheimer’s dementia will be a central question of the Sept. 24 meeting of FDA’s Peripheral & Central Nervous System Drugs Advisory Committee. |
|
Apr 04, 2003 |
|
Article |
New study findings showed Aricept® effective in treating patients with severe Alzheimer's disease
Severe Alzheimer's disease (AD) patients treated with Aricept ® (donepezil HCl tablets) showed significant improvement in global function, cognition, behavior, and activities of daily living versus placebo, according to new data from a subset analysis of the Moderate to Severe Alzheimer's Disease Study (MSAD), previously published in Neurology in August 2001. |
|
Jan 20, 2006 |
|
Article,DrugNews |
Research: New Compound Stops Brain Cell Degeneration in Alzheimer's Disease?
Drug discovery researchers at Northwestern University have developed a novel orally administered compound specifically targeted to suppress brain cell inflammation and neuron loss associated with Alzheimer's disease. |
|
|
Next 10 Articles>> |
|
|
|
